{"transactions":[{"id":786664,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T21:01:07.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":9576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2026 in shares of common stock."}],"balance_after":75859,"source":{"system":"sec-edgar","filing":"0001193125-26-214925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000119312526214925/ownership.xml","form_type":"4"}},{"id":786663,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T21:01:07.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":6331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027."}],"balance_after":66283,"source":{"system":"sec-edgar","filing":"0001193125-26-214925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000119312526214925/ownership.xml","form_type":"4"}},{"id":1129140,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T21:10:58.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":10637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2025 in shares of common stock."}],"balance_after":59952,"source":{"system":"sec-edgar","filing":"0000950170-25-079848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000095017025079848/ownership.xml","form_type":"4"}},{"id":1129139,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T21:10:58.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":7032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal yearly installments beginning May 29, 2026."}],"balance_after":49315,"source":{"system":"sec-edgar","filing":"0000950170-25-079848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000095017025079848/ownership.xml","form_type":"4"}},{"id":1500248,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T23:00:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":3651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2024 in shares of common stock."}],"balance_after":42283,"source":{"system":"sec-edgar","filing":"0000950170-24-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000095017024065502/ownership.xml","form_type":"4"}},{"id":1500247,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T23:00:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":2414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025."}],"balance_after":38632,"source":{"system":"sec-edgar","filing":"0000950170-24-065502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000095017024065502/ownership.xml","form_type":"4"}},{"id":1743761,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2023-11-13T22:46:03.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":68028,"price":73.02,"value":4967404.56,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.90 to $73.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the \"2002 CBW Family Trust\"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust (\"2002 CRW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":653015,"source":{"system":"sec-edgar","filing":"0000950170-23-063176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000095017023063176/ownership.xml","form_type":"4"}},{"id":1884415,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2023-05-19T21:05:08.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3371,"price":71.78,"value":241970.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2023 in shares of common stock."}],"balance_after":36218,"source":{"system":"sec-edgar","filing":"0000899243-23-013383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924323013383/doc4.xml","form_type":"4"}},{"id":1884414,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2023-05-19T21:05:08.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal annual installments beginning May 18, 2024."}],"balance_after":32847,"source":{"system":"sec-edgar","filing":"0000899243-23-013383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924323013383/doc4.xml","form_type":"4"}},{"id":2261664,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:09:23.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":2303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal annual installments beginning May 19, 2023."}],"balance_after":30618,"source":{"system":"sec-edgar","filing":"0000899243-22-019065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924322019065/doc4.xml","form_type":"4"}},{"id":2666076,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-06-16T21:05:18.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":27515,"price":66.47,"value":1828922.05,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares sold by the 2012 CRMW Family Trust."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.97, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":506844,"source":{"system":"sec-edgar","filing":"0000899243-21-024164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924321024164/doc4.xml","form_type":"4"}},{"id":2666075,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-06-16T21:05:18.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":27515,"price":66.47,"value":1828922.05,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $66.27 to $66.89, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned of record as follows: (i) 157,491 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 155,930 shares by the 2012 RBW Jr Family Trust, and (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":534359,"source":{"system":"sec-edgar","filing":"0000899243-21-024164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924321024164/doc4.xml","form_type":"4"}},{"id":2722971,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-05-07T21:05:21.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022."}],"balance_after":28315,"source":{"system":"sec-edgar","filing":"0000899243-21-018708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924321018708/doc4.xml","form_type":"4"}},{"id":2789081,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-03-15T22:27:36.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":109443,"price":59.1208,"value":6470357.7144,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $58.82 to $59.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Following both of the transactions reported in this Form 4, the shares are owned of record as follows: (i) 157,491 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (iv) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":561874,"source":{"system":"sec-edgar","filing":"0000899243-21-011682","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924321011682/doc4.xml","form_type":"4"}},{"id":3111673,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-06-12T23:50:58.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":88978,"price":25.8833,"value":2303044.2674,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares sold by the Halcyon Trust."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $25.32 to $26.55, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Following both of the transactions reported in this Form 4, the shares are owned of record as follows: (i) 266,934 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (iv) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":671317,"source":{"system":"sec-edgar","filing":"0000899243-20-016428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924320016428/doc4.xml","form_type":"4"}},{"id":3111672,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-06-12T23:50:58.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":33333,"price":25.8416,"value":861378.0528,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by Melissa W. Waud, Mr. Waud's wife."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $25.32 to $26.51, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Following both of the transactions reported in this Form 4, the shares are owned of record as follows: (i) 266,934 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iii) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (iv) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, and (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":760295,"source":{"system":"sec-edgar","filing":"0000899243-20-016428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924320016428/doc4.xml","form_type":"4"}},{"id":3150692,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-05-13T21:01:56.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":6609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest over a 3-year period in equal annual installments beginning May 7, 2021."}],"balance_after":25765,"source":{"system":"sec-edgar","filing":"0000899243-20-012994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924320012994/doc4.xml","form_type":"4"}},{"id":3537929,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-05-06T22:50:47.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":4943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest in three equal annual installments beginning May 2, 2020."}],"balance_after":19156,"source":{"system":"sec-edgar","filing":"0000899243-19-012308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924319012308/doc4.xml","form_type":"4"}},{"id":3775639,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-11-02T22:36:30.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":41865,"price":45,"value":1883925.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 15, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.05, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 355,912 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":793628,"source":{"system":"sec-edgar","filing":"0000899243-18-028069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318028069/doc4.xml","form_type":"4"}},{"id":3858974,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-07-31T01:52:55.000Z","date":"2018-07-26","kind":"sale","acquired":false,"shares":8135,"price":45,"value":366075.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 15, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.02, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 397,777 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":835493,"source":{"system":"sec-edgar","filing":"0000899243-18-020783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318020783/doc4.xml","form_type":"4"}},{"id":3945492,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-05-04T21:31:18.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest in three equal annual installments beginning May 3, 2019."}],"balance_after":14213,"source":{"system":"sec-edgar","filing":"0000899243-18-011557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318011557/doc4.xml","form_type":"4"}},{"id":3994544,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-15T21:27:35.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":7698,"price":42.03,"value":323546.94,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.13, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 405,912 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":843628,"source":{"system":"sec-edgar","filing":"0000899243-18-007595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318007595/doc4.xml","form_type":"4"}},{"id":3996230,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-14T22:01:22.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":5400,"price":42.04,"value":227016.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.27, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares are owned of record as follows: (i) 413,610 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":851326,"source":{"system":"sec-edgar","filing":"0000899243-18-007418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318007418/doc4.xml","form_type":"4"}},{"id":3996229,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-14T22:01:22.000Z","date":"2018-03-12","kind":"sale","acquired":false,"shares":36902,"price":42.02,"value":1550622.04,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.07, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":856726,"source":{"system":"sec-edgar","filing":"0000899243-18-007418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318007418/doc4.xml","form_type":"4"}},{"id":4010706,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-07T01:32:06.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":50000,"price":40.07,"value":2003500.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $40.00 to $40.29, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The shares are owned of record as follows: (i) 455,912 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":893628,"source":{"system":"sec-edgar","filing":"0000899243-18-006556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318006556/doc4.xml","form_type":"4"}},{"id":4010705,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-07T01:32:06.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":1080,"price":39.92,"value":43113.6,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $39.91 to $39.96, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":943628,"source":{"system":"sec-edgar","filing":"0000899243-18-006556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318006556/doc4.xml","form_type":"4"}},{"id":4010704,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-07T01:32:06.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":61029,"price":39.49,"value":2410035.21,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $38.91 to $39.90, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":944708,"source":{"system":"sec-edgar","filing":"0000899243-18-006556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318006556/doc4.xml","form_type":"4"}},{"id":4010703,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-07T01:32:06.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":70141,"price":38.19,"value":2678684.79,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $37.90 to $38.84, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":1005737,"source":{"system":"sec-edgar","filing":"0000899243-18-006556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318006556/doc4.xml","form_type":"4"}},{"id":4010702,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-03-07T01:32:06.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":17750,"price":37.69,"value":668997.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on December 14, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $36.90 to $37.88, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":1075878,"source":{"system":"sec-edgar","filing":"0000899243-18-006556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924318006556/doc4.xml","form_type":"4"}},{"id":4128521,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-12-18T22:32:13.000Z","date":"2017-12-15","kind":"gift","acquired":false,"shares":795667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents a pro rata distribution of shares by Crystal Cove LP to its limited partners for no consideration : (i) 3,978 shares to Mr. Waud, (ii) 424,799 to the Reeve B. Waud 2011 Family Trust (the \"2011 Family Trust\"), (iii) 183,445 shares to the Reeve B. Waud Jr. 2012 Family Trust (the \"2012 RBW Jr Family Trust\"), and (iv) 183,445 shares to the Cecily R.M. Waud 2012 Family Trust (the \"2012 CRMW Family Trust\"). The limited partners acquired their indirect interest in the shares held by Crystal Cove LP as a result of gifts from Mr. Waud and certain affiliated family trusts. Mr. Waud may be deemed to retain an indirect beneficial ownership in all of the shares distributed by Crystal Cove LP (other than shares distributed to him personally) by virtue of the relationships described in Footnote (7)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The shares are owned of record as follows: (i) 231,113 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by WCP LLC, (iv) 424,799 shares by the 2011 Family Trust, (v) 183,445 shares by the 2012 RBW Jr Family Trust, and (vi) 183,445 shares by the 2012 CRMW Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust and of the 2011 Family Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":1093628,"source":{"system":"sec-edgar","filing":"0000899243-17-029059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317029059/doc4.xml","form_type":"4"}},{"id":4128520,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-12-18T22:32:13.000Z","date":"2017-12-15","kind":"sale","acquired":false,"shares":100000,"price":31.797,"value":3179700.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $31.57 to $32.16, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reported shares were owned of record as follows: (i) 231,113 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), and (iv) 795,667 by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC and (D) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":1097606,"source":{"system":"sec-edgar","filing":"0000899243-17-029059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317029059/doc4.xml","form_type":"4"}},{"id":4227479,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-08-22T22:40:34.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":984075,"price":50.69,"value":49882761.75,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in an underwritten offering as follows: (i) 193,745 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 354,195 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 54,057 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") (iv) 31,097 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (v) 175,851 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (vi) 77,176 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\") (vii) 55,363 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\") (viii) 28,412 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\") and (ix) 14,179 shares by Waud Family Partners, L.P. (\"WFP LP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares are owned of record as follows: (i) 331,113 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\") and (iv) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":1197606,"source":{"system":"sec-edgar","filing":"0000899243-17-020885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317020885/doc4.xml","form_type":"4"}},{"id":4247256,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-08-01T22:14:19.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":1190000,"price":51.65,"value":61463500.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares sold under Rule 144 as follows: (i) 234,287 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 428,316 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 65,368 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") (iv) 37,604 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (v) 212,649 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (vi) 93,325 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\") (vii) 66,948 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\") (viii) 34,358 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\") and (ix) 17,145 shares by Waud Family Partners, L.P. (\"WFP LP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The shares are owned of record as follows: (i) 193,745 shares by WCP II, (ii) 354,195 shares by WCP QP II, (iii) 54,057 by WCP FIF II, (iv) 31,097 shares by WCP III, (v) 175,851 shares by WCP QP III, (vi) 77,176 shares by WCP FIF III, (vii) 55,363 shares by Waud Affiliates II, (viii) 28,412 shares by Waud Affiliates III, (ix) 331,113 shares by the Halcyon Trust, (x) 14,179  shares by WFP LP, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\") and (xiii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":2181681,"source":{"system":"sec-edgar","filing":"0000899243-17-019440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317019440/doc4.xml","form_type":"4"}},{"id":4247255,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-08-01T22:14:19.000Z","date":"2017-07-28","kind":"sale","acquired":false,"shares":15400,"price":53.63,"value":825902.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $53.50 to $53.82, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":3371681,"source":{"system":"sec-edgar","filing":"0000899243-17-019440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317019440/doc4.xml","form_type":"4"}},{"id":4247254,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-08-01T22:14:19.000Z","date":"2017-07-28","kind":"sale","acquired":false,"shares":34600,"price":53.13,"value":1838298.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $52.50 to $53.49, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":3387081,"source":{"system":"sec-edgar","filing":"0000899243-17-019440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317019440/doc4.xml","form_type":"4"}},{"id":4261741,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-07-06T21:53:10.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":50000,"price":50.043,"value":2502150.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.17, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 428,032 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 782,511 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 119,425 by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (iv) 122,311 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (v) 62,770 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (vi) 170,501 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (vii) 388,500 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (viii) 68,701 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ix) 381,113 shares by the Halcyon Trust, (x) 31,324  shares by Waud Family Partners, L.P. (\"WFP LP\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":3421681,"source":{"system":"sec-edgar","filing":"0000899243-17-018000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317018000/doc4.xml","form_type":"4"}},{"id":4273440,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-06-23T20:10:59.000Z","date":"2017-06-22","kind":"sale","acquired":false,"shares":50000,"price":47.512,"value":2375600.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") on March 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $47.50 to $47.57, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 428,032 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 782,511 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 119,425 by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (iv) 122,311 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (v) 62,770 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (vi) 170,501 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (vii) 388,500 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (viii) 68,701 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ix) 431,113 shares by the Halcyon Trust, (x) 31,324  shares by Waud Family Partners, L.P. (\"WFP LP\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":3471681,"source":{"system":"sec-edgar","filing":"0000899243-17-017080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317017080/doc4.xml","form_type":"4"}},{"id":4280606,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-06-15T20:14:04.000Z","date":"2017-06-14","kind":"sale","acquired":false,"shares":724694,"price":45.53,"value":32995317.82,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold under Rule 144 as follows: (i) 142,678 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 260,837 shares by Waud Capital Partners QP II, L.P. (\"Waud QP II\"), (iii) 39,808 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") (iv) 22,901 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (v) 129,500 shares by Waud Capital Partners QP III, L.P. (\"Waud QP III\"), (vi) 56,834 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\") (vii) 40,771 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\") (viii) 20,924 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\") and (ix) 10,441 shares by Waud Family Partners, L.P. (\"WFP LP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares are owned of record as follows: (i) 428,032 shares by WCP II, (ii) 782,511 shares by WCP QP II, (iii) 119,425 by WCP FIF II, (iv) 68,701 shares by WCP III, (v) 388,500 shares by WCP QP III, (v) 170,501 shares by WCP FIF III, (vi) 122,311 shares by Waud Affiliates II, (vii) 62,770 shares by Waud Affiliates III, (viii) 481,113 shares by the Halcyon Trust, (ix) 31,324 shares by WFP LP, (x) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xi) 37,493 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\") and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":3521681,"source":{"system":"sec-edgar","filing":"0000899243-17-016459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317016459/doc4.xml","form_type":"4"}},{"id":4283611,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-06-13T10:06:16.000Z","date":"2017-06-09","kind":"sale","acquired":false,"shares":50000,"price":45.087,"value":2254350.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family (the \"Halcyon Trust\") on March 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.25, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The shares are owned of record as follows: (i) 570,710 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 1,043,348 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 159,233 by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (iv) 163,082 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (v) 83,694 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (vi) 227,335 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (vii) 518,000 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (viii) 91,602 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ix) 481,113 shares by the Halcyon Trust, (x) 41,765 shares by Waud Family Partners, L.P. (\"WFP LP\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":4246375,"source":{"system":"sec-edgar","filing":"0000899243-17-016149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317016149/doc4.xml","form_type":"4"}},{"id":4302891,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-05-26T21:00:05.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are held of record by Mr. Reeve B. Waud for the benefit of Waud Capital Partners, L.L.C. (\"WCP LLC\"), of which Mr. Waud is the sole manager. The shares will vest in three equal annual installments beginning May 25, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents shares held of record for the benefit of WCP LLC."}],"balance_after":6110,"source":{"system":"sec-edgar","filing":"0000899243-17-014565","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317014565/doc4.xml","form_type":"4"}},{"id":4379800,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2017-03-17T20:48:16.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":51118,"price":41.06,"value":2098905.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares sold by Mr. Waud under Rule 144."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Represents shares held for the benefit of WCP LLC."}],"balance_after":4555,"source":{"system":"sec-edgar","filing":"0000899243-17-007997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317007997/doc4.xml","form_type":"4"}},{"id":4379799,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2017-03-17T20:48:16.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":2973773,"price":41.06,"value":122103119.38,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold under Rule 144 as follows: (i) 570,710 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 1,043,349 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 159,233 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") (iv) 163,082 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (v) 83,694 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (vi) 227,336 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (vii) 518,001 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (viii) 91,603 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ix) 75,000 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\") and (x) 41,765 shares by Waud Family Partners, L.P. (\"WFP LP\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares are owned of record as follows: (i) 570,710 shares by WCP II, (ii) 1,043,348 shares by WCP QP II, (iii) 159,233 shares by WCP FIF II, (iv) 163,082 shares by Waud Affiliates II, (v) 83,694 shares by Waud Affiliates III, (vi) 227,335 shares by WCP FIF III, (vii) 518,000 shares by WCP QP III, (viii) 91,602 shares by WCP III, (ix) 531,113 shares by the Halcyon Trust, (x) 41,765 shares by WFP LP, (xi)  33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\") and (xiii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":4294178,"source":{"system":"sec-edgar","filing":"0000899243-17-007997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924317007997/doc4.xml","form_type":"4"}},{"id":4518755,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-17T01:10:08.000Z","date":"2016-12-16","kind":"sale","acquired":false,"shares":14000,"price":35.14,"value":491960.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.69 to $35.61, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The shares are owned of record as follows: (i) 1,141,420 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 2,086,697 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 606,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. (\"WFP LP\"), (v) 318,466 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (vi) 326,164 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (vii) 167,388 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (viii) 454,671 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (ix) 1,036,001 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (x) 183,205 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7267951,"source":{"system":"sec-edgar","filing":"0000899243-16-035846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035846/doc4.xml","form_type":"4"}},{"id":4518754,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-17T01:10:08.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":8913,"price":34.23,"value":305091.99,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.01 to $34.44, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7281951,"source":{"system":"sec-edgar","filing":"0000899243-16-035846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035846/doc4.xml","form_type":"4"}},{"id":4518753,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-17T01:10:08.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":5087,"price":33.67,"value":171279.29,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $33.01 to $34.00, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission (the \"Commission\"), upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7290864,"source":{"system":"sec-edgar","filing":"0000899243-16-035846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035846/doc4.xml","form_type":"4"}},{"id":4522052,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-15T00:55:59.000Z","date":"2016-12-14","kind":"sale","acquired":false,"shares":700,"price":33.88,"value":23716.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $33.68 to $34.36, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"The shares are owned of record as follows: (i) 1,141,420 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 2,086,697 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 634,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. (\"WFP LP\"), (v) 318,466 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (vi) 326,164 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (vii) 167,388 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (viii) 454,671 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (ix) 1,036,001 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\"), (x) 183,205 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7295951,"source":{"system":"sec-edgar","filing":"0000899243-16-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035571/doc4.xml","form_type":"4"}},{"id":4522051,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-15T00:55:59.000Z","date":"2016-12-14","kind":"sale","acquired":false,"shares":13300,"price":33.2,"value":441560.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $32.68 to $33.67, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7296651,"source":{"system":"sec-edgar","filing":"0000899243-16-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035571/doc4.xml","form_type":"4"}},{"id":4522050,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-15T00:55:59.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":5159,"price":35.51,"value":183196.09,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $35.31 to $35.97, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7309951,"source":{"system":"sec-edgar","filing":"0000899243-16-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035571/doc4.xml","form_type":"4"}},{"id":4522049,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-15T00:55:59.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":8841,"price":34.86,"value":308197.26,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $34.31 to $35.305, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7315110,"source":{"system":"sec-edgar","filing":"0000899243-16-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035571/doc4.xml","form_type":"4"}},{"id":4522048,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-12-15T00:55:59.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":14000,"price":35.79,"value":501060.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions under Rule 144 at prices ranging from $35.69 to $36.01, inclusive. The reporting person further undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission (the \"Commission\"), upon request, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7323951,"source":{"system":"sec-edgar","filing":"0000899243-16-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316035571/doc4.xml","form_type":"4"}},{"id":4601458,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":75000,"price":50.76,"value":3807000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Represents shares sold in multiple transactions under Rule 144 by the Halcyon Exempt Family Trust (the \"Halcyon Trust\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.70 to $51.12, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote (9) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F14","text":"The shares are owned of record as follows: (i) 1,141,420 shares by WCP II, (ii) 2,086,697 shares by WCP QP II, (iii) 676,113 shares by the Halcyon Trust, (iv) 83,530 shares by Waud Family Partners, L.P. (\"WFP LP\"), (v) 318,466 shares by WCP FIF II, (vi) 326,164 shares by Waud Affiliates II, (vii) 167,388 shares by Waud Affiliates III, (viii) 454,671 shares by WCP FIF III, (ix) 1,036,001 shares by WCP QP III, (x) 183,205 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Mr. Waud is the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7337951,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601457,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":287668,"price":47.74,"value":13733270.32,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Represents shares sold as follows: (i) 7,170 shares by WCP III, (ii) 158,116 shares by Waud QP III, (iii) 89,451 shares by WCP FIF III and (iv) 32,931 shares by Waud Affiliates III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7412951,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601456,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":521033,"price":47.74,"value":24874115.42,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares sold as follows: (i) 98,073 shares by WCP II, (ii) 296,136 shares by Waud QP II, (iii) 62,655 shares by WCP FIF II and (iv) 64,169 shares by Waud Affiliates II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":7700619,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601455,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-15","kind":"sale","acquired":false,"shares":123473,"price":49.24,"value":6079810.52,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares sold in market transactions under Rule 144 as follows: (i) 3,077 shares by WCP III, (ii) 67,867 shares by Waud QP III, (iii) 38,394 shares by WCP FIF III and (iv) 14,135 shares by Waud Affiliates III."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8221652,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601454,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-15","kind":"sale","acquired":false,"shares":223640,"price":49.24,"value":11012033.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares sold in multiple transactions under Rule 144 as follows: (i) 42,095 shares by WCP II, (ii) 127,109 shares by Waud QP II, (iii) 26,893 shares by WCP FIF II and (iv) 27,543 shares by Waud Affiliates II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $49.00 to $49.67, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8345125,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601453,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":46302,"price":50.19,"value":2323897.38,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold in market transactions under Rule 144 as follows: (i) 1,154 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ii) 25,449 shares by Waud Capital Partners QP III, L.P. (\"Waud QP III\"), (iii) 14,397 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\") and (iv) 5,302 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8568765,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4601452,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-16T23:25:57.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":83861,"price":50.19,"value":4208983.59,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 as follows: (i) 15,785 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 47,664 shares by Waud Capital Partners QP II, L.P. (\"Waud QP II\"), (iii) 10,084 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") and (iv) 10,328 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.54, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8615067,"source":{"system":"sec-edgar","filing":"0000899243-16-029178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029178/doc4.xml","form_type":"4"}},{"id":4603322,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-15T01:03:45.000Z","date":"2016-09-13","kind":"sale","acquired":false,"shares":3275,"price":51.23,"value":167778.25,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares sold in market transactions under Rule 144 as follows: (i) 82 shares by WCP III, (ii) 1,800 shares by Waud QP III, (iii) 1,019 shares by WCP FIF III and (iv) 374 shares by Waud Affiliates III."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"The shares are owned of record as follows: (i) 1,297,373 shares by WCP II, (ii) 2,557,606 shares by WCP QP II, (iii) 751,113 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (iv) 83,530 shares by Waud Family Partners, L.P. (\"WFP LP\"), (v) 418,098 shares by WCP FIF II, (vi) 428,204 shares by Waud Affiliates II, (vii) 219,756 shares by Waud Affiliates III, (viii) 596,913 shares by WCP FIF III, (ix) 1,287,433 shares by WCP QP III, (x) 194,606 shares by WCP III, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by Waud Capital Partners, L.L.C. (\"WCP LLC\"), and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8698928,"source":{"system":"sec-edgar","filing":"0000899243-16-029006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029006/doc4.xml","form_type":"4"}},{"id":4603321,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-15T01:03:45.000Z","date":"2016-09-13","kind":"sale","acquired":false,"shares":5933,"price":51.23,"value":303947.59,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares sold in multiple transactions under Rule 144 as follows: (i) 1,117 shares by WCP II, (ii) 3,372 shares by Waud QP II, (iii) 713 shares by WCP FIF II and (iv) 731 shares by Waud Affiliates II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.15 to $51.85, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (6) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8702203,"source":{"system":"sec-edgar","filing":"0000899243-16-029006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029006/doc4.xml","form_type":"4"}},{"id":4603320,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-15T01:03:45.000Z","date":"2016-09-12","kind":"sale","acquired":false,"shares":26679,"price":51.77,"value":1381171.83,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold in market transactions under Rule 144 as follows: (i) 665 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (ii) 14,664 shares by Waud Capital Partners QP III, L.P. (\"Waud QP III\"), (iii) 8,296 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\")  and (iv) 3,054 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8708136,"source":{"system":"sec-edgar","filing":"0000899243-16-029006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029006/doc4.xml","form_type":"4"}},{"id":4603319,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-15T01:03:45.000Z","date":"2016-09-12","kind":"sale","acquired":false,"shares":48321,"price":51.77,"value":2501578.17,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in multiple transactions under Rule 144 as follows: (i) 9,095 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 27,464 shares by Waud Capital Partners QP II, L.P. (\"Waud QP II\"), (iii) 5,811 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\") and (iv) 5,951 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $51.58 to $52.01, inclusive. The reporting persons undertake to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (1) and (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (9) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8734815,"source":{"system":"sec-edgar","filing":"0000899243-16-029006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316029006/doc4.xml","form_type":"4"}},{"id":4604288,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":48690,"kind":"person","name":"WAUD REEVE B","position":1,"cik":"0001421620","reported_name":"WAUD REEVE B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common stock, par value $0.01 per share","published_at":"2016-09-13T22:57:53.000Z","date":"2016-09-09","kind":"other","acquired":false,"shares":534488,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 193,821 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 48,921 shares by Waud Capital Partners III, L.P. (\"WCP III\") and (iv) 77,438 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents pro rata in-kind distributions for no consideration to certain of the limited partners of the following Reporting Persons: (i) 214,308 shares by Waud Capital Partners II, L.P. (\"WCP II\"), (ii) 193,821 shares by Waud Capital Partners QP II, L.P. (\"WCP QP II\"), (iii) 48,921 shares by Waud Capital Partners III, L.P. (\"WCP III\") and (iv) 77,438 shares by Waud Capital Partners QP III, L.P. (\"WCP QP III\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The shares are owned of record as follows: (i) 1,307,585 shares by WCP II, (ii) 2,588,442 shares by WCP QP II, (iii) 751,113 shares by the Halcyon Exempt Family Trust (the \"Halcyon Trust\"), (iv) 83,530 shares by Waud Family Partners, L.P. (\"WFP LP\"), (v) 424,622 shares by WCP FIF II (Acadia), L.P. (\"WCP FIF II\"), (vi) 434,886 shares by Waud Capital Affiliates II, L.L.C. (\"Waud Affiliates II\"), (vii) 223,184 shares by Waud Capital Affiliates III, L.L.C. (\"Waud Affiliates III\"), (viii) 606,228 shares by WCP FIF III (Acadia), L.P. (\"WCP FIF III\"), (ix) 1,303,897 shares by WCP QP III, (x) 195,353 shares by Waud Capital Partners III, L.P. (\"WCP III\"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 35,296 shares by WCP LLC, and (xii) 795,667 shares by Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Waud Capital Partners Management II, L.P. (\"WCPM II\") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. (\"WCP II LLC\") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. (\"WCPM III\") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. (\"WCP III LLC\") is the general partner of WCPM III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (2) by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":8783136,"source":{"system":"sec-edgar","filing":"0000899243-16-028908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1421620/000089924316028908/doc4.xml","form_type":"4"}}]}